Samantha Pozzi
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.
Journal: HemaSphere
Published: April 02, 2026
Dissecting diffuse large B-cell lymphoma heterogeneity: New insights from a state-specific molecular characterisation.
Journal: Clinical and translational medicine
Published: March 24, 2026
A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genes.
Journal: International journal of laboratory hematology
Published: December 09, 2023
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study).
Journal: Hematological oncology
Published: March 13, 2022
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study.
Journal: Cancers
Published: November 26, 2021
Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma.
Journal: Cancers
Published: August 12, 2021
Cytokine Release Syndrome Associated with T-Cell-Based Therapies for Hematological Malignancies: Pathophysiology, Clinical Presentation, and Treatment.
Journal: International journal of molecular sciences
Published: July 09, 2021
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting.
Journal: Leukemia research
Published: November 11, 2020
Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: August 26, 2020
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination.
Journal: Apoptosis : an international journal on programmed cell death
Published: May 13, 2020
Last Updated: 09/26/2026